New Key Statistics Module, Z-Score and F-Score
SZSE:002898 Key Ratios
Market Cap ¥ M | 1,971.20 |
Enterprise Value ¥ M | 2,079.78 |
P/E(ttm) | 1,244.44 |
PE Ratio without NRI | 509.09 |
Forward PE Ratio | -- |
Price/Book | 3.73 |
Price/Sales | 6.51 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.91 |
Revenue (TTM) ¥ M | 303.00 |
EPS (TTM) ¥ | 0.009 |
Beneish M-Score | -2.08 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 138.34 |
EV-to-EBITDA | 138.34 |
PEG | -- |
Shares Outstanding M | 176.00 |
Net Margin (%) | 0.50 |
Operating Margin % | 5.75 |
Pre-tax Margin (%) | 2.77 |
Quick Ratio | 0.75 |
Current Ratio | 1.10 |
ROA % (ttm) | 0.19 |
ROE % (ttm) | 0.28 |
ROIC % (ttm) | 0.45 |
Dividend Yield % | 0.18 |
Altman Z-Score | 4.33 |
SZSE:002898 Number of Guru Trades
SZSE:002898 Volume of Guru Trades
Gurus Latest Trades with SZSE:002898
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002898 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sailong Pharmaceutical Group Co Ltd Insider Transactions
No Available Data